CHRISTINA LAKE CANNABIS (F:CLB) — Market Cap & Net Worth
Market Cap & Net Worth: CHRISTINA LAKE CANNABIS (CLB)
CHRISTINA LAKE CANNABIS (F:CLB) has a market capitalization of $290.05K (€248.09K) as of September 8, 2026. Listed on the F stock exchange, this Germany-based company holds position #31182 globally and #2757 in its home market, demonstrating a -90.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CHRISTINA LAKE CANNABIS's stock price €0.00 by its total outstanding shares 248093567 (248.09 Million). Also see CLB asset base for a full breakdown of the balance sheet.
CHRISTINA LAKE CANNABIS Market Cap History: 2020 to 2026
CHRISTINA LAKE CANNABIS's market capitalization history from 2020 to 2026. Data shows change from $136.32 Million to $290.05K (-60.64% CAGR). Also see CHRISTINA LAKE CANNABIS cash flow conversion for how efficiently the company converts equity into cash flow.
CHRISTINA LAKE CANNABIS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CHRISTINA LAKE CANNABIS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest CHRISTINA LAKE CANNABIS stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.15x
CHRISTINA LAKE CANNABIS's market cap is 0.15 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.35x
CHRISTINA LAKE CANNABIS's market cap is 2.35 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $44.67 Million | $3.63 Million | -$7.14 Million | 12.29x | N/A |
| 2022 | $12.09 Million | $10.07 Million | -$2.03 Million | 1.20x | N/A |
| 2023 | $2.32 Million | $11.78 Million | -$4.13 Million | 0.20x | N/A |
| 2024 | $2.03 Million | $13.61 Million | $865.00K | 0.15x | 2.35x |
Competitor Companies of CLB by Market Capitalization
Companies near CHRISTINA LAKE CANNABIS in the global market cap rankings as of September 8, 2026. Review CLB tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to CHRISTINA LAKE CANNABIS by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #525 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #610 globally with a market cap of $45.51 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #633 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #638 globally with a market cap of $43.18 Billion USD ( CN¥295.09 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #525 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #610 | GALDERMA GROUP AG | NYSE:GALDY | $45.51 Billion | $39.03 |
| #633 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €15.90 |
| #638 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $43.18 Billion | CN¥46.26 |
CHRISTINA LAKE CANNABIS Historical Marketcap From 2020 to 2026
Between 2020 and today, CHRISTINA LAKE CANNABIS's market cap moved from $136.32 Million to $ 290.05K, with a yearly change of -60.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €290.05K | -94.44% |
| 2025 | €5.22 Million | +157.14% |
| 2024 | €2.03 Million | -12.50% |
| 2023 | €2.32 Million | -80.82% |
| 2022 | €12.09 Million | -72.92% |
| 2021 | €44.67 Million | -67.23% |
| 2020 | €136.32 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 8th, 2026 the market cap of CHRISTINA LAKE CANNABIS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $290.05K USD |
| MoneyControl | $290.05K USD |
| MarketWatch | $290.05K USD |
| marketcap.company | $290.05K USD |
| Reuters | $290.05K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CHRISTINA LAKE CANNABIS
Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It offers distilled and winterized oils; kief products; and additional extracted products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christin… Read more